Literature DB >> 11034468

Medical or surgical treatment for chronic gastrooesophageal reflux? A systematic review of published evidence of effectiveness.

P C Allgood1, M Bachmann.   

Abstract

OBJECTIVE: To compare the effectiveness of medical (antacids, histamine antagonists and proton pump inhibitors) and surgical (fundoplication) treatment of chronic GORD.
SUBJECTS: Patients with objective (endoscopic or pH) evidence of chronic reflux reported in 6 randomised trials and 3 cohort studies, 1966-1999.
METHODS: Systematic review of comparative studies identified from electronic searches, citations, manual searches of journals, and correspondence with authors and experts. MAIN OUTCOME MEASURES: Improvements in prevalence or severity of symptoms, oesophagitis, pH reflux duration, lower oesophageal sphincter pressure, patients' satisfaction, and side-effects.
RESULTS: Improved outcomes were more common after surgical than medical treatment with significant differences in objective outcomes in 5/6 randomised trials and in 2/3 cohort studies. Subjective outcomes (symptoms and patients' satisfaction) were also more common among surgical patients in all but one study that assessed them. Odds ratios for improvement with surgical rather than medical treatment ranged from 1.2 to 200, and numbers needed to treat ranged from 1.2 to 58, where these could be calculated. Studies were too heterogeneous for meta-analysis.
CONCLUSIONS: In trials of chronic severe GORD, surgery is consistently more effective than medical treatment in relieving symptoms and objective oesophagitis, although omeprazole can give similar symptom relief with adjustment of the dose.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11034468     DOI: 10.1080/110241500750008475

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  7 in total

Review 1.  Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis.

Authors:  Nadja Rickenbacher; Thomas Kötter; Michael M Kochen; Martin Scherer; Eva Blozik
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

2.  Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.

Authors:  Bart P L Witteman; Jose M Conchillo; Nicolaas F Rinsma; Bark Betzel; Andrea Peeters; Ger H Koek; Laurents P S Stassen; Nicole D Bouvy
Journal:  Am J Gastroenterol       Date:  2015-03-31       Impact factor: 10.864

Review 3.  Gastro-oesophageal reflux and bronchial asthma: current status and future directions.

Authors:  J L Mathew; M Singh; S K Mittal
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

Review 4.  Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs.

Authors:  J Dent; D Armstrong; B Delaney; P Moayyedi; N J Talley; N Vakil
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

5.  Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX.

Authors:  Guy-Bernard Cadière; Nathalie Van Sante; Jaime E Graves; Anna K Gawlicka; Amin Rajan
Journal:  Surg Endosc       Date:  2009-03-14       Impact factor: 4.584

Review 6.  GORD in adults.

Authors:  Paul Moayyedi; Brendan Delaney
Journal:  BMJ Clin Evid       Date:  2008-06-13

7.  Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study.

Authors:  Guy-Bernard Cadière; Michel Buset; Vinciane Muls; Amin Rajan; Thomas Rösch; Alexander J Eckardt; Joseph Weerts; Boris Bastens; Guido Costamagna; Michele Marchese; Hubert Louis; Fazia Mana; Filip Sermon; Anna K Gawlicka; Michael A Daniel; Jacques Devière
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.